As CMT1A disease affects mSC number and therefore myelin amount in nerves, we used Western blot to measure the amount of myelin marker MPZ over the total amount of protein after AAV2/9-sh1 and -sh2 treatment (Fig. 3a). The gene discussed is MPZ; the disease is Charcot-Marie-Tooth disease type 1A.